Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs
Authors:
- 8 August 2013
- journal article
- other
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 111 (5) , 1048-1053
Abstract
Sickle cell disease (SCD) is the most common human genetic disease which is caused by a single mutation of human β‐globin (HBB) gene. The lack of long‐term treatment makes the development of reliable cell and gene therapies highly desirable. Disease‐specific patient‐derived human induced pluripotent stem cells (hiPSCs) have great potential for developing novel cell and gene therapies. With the disease‐causing mutations corrected in situ, patient‐derived hiPSCs can restore normal cell functions and serve as a renewable autologous cell source for the treatment of genetic disorders. Here we successfully utilized transcription activator‐like effector nucleases (TALENs), a recently emerged novel genome editing tool, to correct the SCD mutation in patient‐derived hiPSCs. The TALENs we have engineered are highly specific and generate minimal off‐target effects. In combination with piggyBac transposon, TALEN‐mediated gene targeting leaves no residual ectopic sequences at the site of correction and the corrected hiPSCs retain full pluripotency and a normal karyotype. Our study demonstrates an important first step of using TALENs for the treatment of genetic diseases such as SCD, which represents a significant advance toward hiPSC‐based cell and gene therapies. Biotechnol. Biotechnol. Bioeng. 2014;111: 1048–1053.Keywords
This publication has 19 references indexed in Scilit:
- TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target predictionNucleic Acids Research, 2012
- Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell diseaseBlood, 2011
- In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger NucleasesStem Cells, 2011
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selectionNature Methods, 2011
- Genetic engineering of human pluripotent cells using TALE nucleasesNature Biotechnology, 2011
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point MutationsCell, 2011
- Short DNA sequences inserted for gene targeting can accidentally interfere with off‐target gene expressionThe FASEB Journal, 2010
- Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleasesNature Biotechnology, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007